CD35: Complement receptor type 1

被引：0
|
作者：
Krych, M [1 ]
Molina, H [1 ]
Atkinson, JP [1 ]
机构：
[1] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA
来源：
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS | 1999年 / 13卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：229 / 233
页数：5
相关论文
共 50 条
  • [31] Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients
    Kremlitzka, Mariann
    Polgar, Anna
    Fueloep, Livia
    Kiss, Emese
    Poor, Gyula
    Erdei, Anna
    INTERNATIONAL IMMUNOLOGY, 2013, 25 (01) : 25 - 33
  • [32] Human Umbilical Vein Endothelial Cells Express Complement Receptor 1 (CD35) and Complement Receptor 4 (CD11c/CD18) in vitro
    Harald Langeggen
    Knut Erik Berge
    Egil Johnson
    Geir Hetland
    Inflammation, 2002, 26 : 103 - 110
  • [33] Soluble complement receptor 1 (CD35) bound to immune complexes in sera of patients with systemic lupus erythematosus
    Csipo, I
    Kiss, E
    Bako, E
    Szegedi, G
    Kavai, M
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : 2950 - 2951
  • [34] The complement receptor 1, CR1 (CD35), mediates inhibitory signals in human T-lymphocytes
    Wagner, C
    Ochmann, C
    Schoels, M
    Giese, T
    Stegmaier, S
    Richter, R
    Hug, F
    Hänsch, GM
    MOLECULAR IMMUNOLOGY, 2006, 43 (06) : 643 - 651
  • [35] Complement receptors CD21 and CD35 in humoral immunity
    Roozendaal, Ramon
    Carroll, Michael C.
    IMMUNOLOGICAL REVIEWS, 2007, 219 : 157 - 166
  • [36] Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV-infected patients
    Sadallah, S
    Hess, C
    Trendelenburg, M
    Vedeler, C
    Lopez-Trascasa, M
    Schifferli, IA
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 131 (01): : 174 - 181
  • [37] Complement-activating antibodies in sera from infected individuals and vaccinated volunteers that target human immunodeficiency virus type 1 to complement receptor type 1 (CR1, CD35)
    Zhou, JT
    Montefiori, DC
    VIROLOGY, 1996, 226 (01) : 13 - 21
  • [38] Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney
    Java, Anuja
    Liszewski, M. Kathryn
    Hourcade, Dennis E.
    Zhang, Fan
    Atkinson, John P.
    MOLECULAR IMMUNOLOGY, 2015, 67 (02) : 584 - 595
  • [39] Decay accelerating activity of complement receptor type 1 (CD35) - Two active sites are required for dissociating C5 convertases
    Krych-Goldberg, M
    Hauhart, RE
    Subramanian, VB
    Yurcisin, BM
    Crimmins, DL
    Hourcade, DE
    Atkinson, JP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (44) : 31160 - 31168
  • [40] Decay accelerating activity of complement receptor type 1 (CD35): Two active sites are required for dissociating C5 convertases
    Krych-Goldberg, Malgorzata
    Hauhart, Richard E.
    Subramanian, V. Bala
    Yurcisin, II, Basil M.
    Crimmins, Daniel L.
    Hourcade, Dennis E.
    Atkinson, John P.
    Journal of Biological Chemistry, 274 (44): : 31160 - 31168
12345